EP4720348A2 - Verfahren zur abschwächung von methylierungsbias - Google Patents

Verfahren zur abschwächung von methylierungsbias

Info

Publication number
EP4720348A2
EP4720348A2 EP24811907.5A EP24811907A EP4720348A2 EP 4720348 A2 EP4720348 A2 EP 4720348A2 EP 24811907 A EP24811907 A EP 24811907A EP 4720348 A2 EP4720348 A2 EP 4720348A2
Authority
EP
European Patent Office
Prior art keywords
nucleic acid
dna
reaction
methylation
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24811907.5A
Other languages
English (en)
French (fr)
Inventor
Nicole Lambert
James Yu
Neil PETERMAN
Yexun Wang
Alexander Robertson
Jason CLOSE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foundation Medicine Inc
Original Assignee
Foundation Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foundation Medicine Inc filed Critical Foundation Medicine Inc
Publication of EP4720348A2 publication Critical patent/EP4720348A2/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855Ligating adaptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP24811907.5A 2023-05-24 2024-05-23 Verfahren zur abschwächung von methylierungsbias Pending EP4720348A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363468742P 2023-05-24 2023-05-24
PCT/US2024/030762 WO2024243407A2 (en) 2023-05-24 2024-05-23 Methods for mitigation of methylation bias

Publications (1)

Publication Number Publication Date
EP4720348A2 true EP4720348A2 (de) 2026-04-08

Family

ID=93590479

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24811907.5A Pending EP4720348A2 (de) 2023-05-24 2024-05-23 Verfahren zur abschwächung von methylierungsbias

Country Status (3)

Country Link
EP (1) EP4720348A2 (de)
CN (1) CN121532527A (de)
WO (1) WO2024243407A2 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11060145B2 (en) * 2013-03-13 2021-07-13 Sequenom, Inc. Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
GB201405226D0 (en) * 2014-03-24 2014-05-07 Cambridge Entpr Ltd Nucleic acid preparation method
KR20220015367A (ko) * 2019-05-31 2022-02-08 프리놈 홀딩스, 인크. 메틸화된 핵산의 고심도 시퀀싱 방법 및 시스템
CN119923475A (zh) * 2022-07-21 2025-05-02 夸登特健康公司 用于检测和减少样品制备诱导的甲基化人为假象的方法

Also Published As

Publication number Publication date
WO2024243407A3 (en) 2025-05-08
CN121532527A (zh) 2026-02-13
WO2024243407A2 (en) 2024-11-28

Similar Documents

Publication Publication Date Title
EP4623107A1 (de) Systeme und verfahren zur verfolgung personalisierter methylierungsbiomarker zum nachweis von krankheiten
WO2024081769A2 (en) Methods and systems for detection of cancer based on dna methylation of specific cpg sites
EP4713485A2 (de) Sequenzierungsadapter zur methylierungssequenzierung
EP4665872A1 (de) Klassifizierung von proben auf der grundlage der methylierungsanalyse von dna-fragmenten
WO2024118594A1 (en) Methods and systems for mutation signature attribution
WO2023183750A1 (en) Methods and systems for determining tumor heterogeneity
EP4496906A1 (de) Charakterisierung von tumorheterogenität als prognostischer biomarker
US20250372256A1 (en) Ancestry-related kras co-alteration patterns as prognostic biomarkers
US20250305060A1 (en) Pole variant classification strategy identifies patients who may have a favorable prognosis and benefit from immunotherapy
EP4720348A2 (de) Verfahren zur abschwächung von methylierungsbias
US20260011406A1 (en) Methods and systems for determining clonality of somatic short variants
US20250188536A1 (en) Methods and systems for prediction of alt status
US20250154604A1 (en) Methods and systems for determining circulating tumor dna fraction in a patient sample
US20250125008A1 (en) Methods and systems for evaluation of sex biases in identifying molecular biomarkers for disease
US20250273294A1 (en) Methods and systems for detection of reversion mutations from genomic profiling data
WO2025029655A1 (en) Methods and systems for detecting integration of transposable elements
WO2024050242A1 (en) Methods and systems for detecting tumor shedding
WO2024112643A1 (en) Fragmentomics based identification of tumor-specific copy number alteration states in liquid biopsy
WO2024182272A2 (en) Systems and methods for identifying mitochondrial dna variants
EP4713490A1 (de) Verfahren und systeme zur beurteilung der zirkulierenden tumor-dna-fraktion in flüssigen biopsieproben
WO2025128727A1 (en) Methods and systems for preparing a sequencing library
WO2025024307A2 (en) Methods and systems for detecting rna contaminants in a sample
WO2024112752A1 (en) Methods to identify false-positive disease therapy associations and improve clinical reporting for patients
WO2025128580A1 (en) Methods and systems for determining methylation state categories
WO2024064679A1 (en) Methods and systems for functional status assignment of genomic variants

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251219

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR